Literature DB >> 2900735

Species differences in the stereoselective hydrolysis of esmolol by blood esterases.

C Y Quon1, K Mai, G Patil, H F Stampfli.   

Abstract

The stereoselective hydrolysis of esmolol was examined in blood from several species including humans. Blood esmolol esterase activity was in the order of guinea pigs greater than rats greater than rabbits greater than dogs greater than rhesus monkeys greater than humans. Dog and rat blood esterases hydrolyzed the (-)-enantiomer of esmolol faster than the (+)-enantiomer whereas rhesus monkey, rabbit, and guinea pig blood esterases hydrolyzed the (+)-enantiomer faster. Human blood esterases did not demonstrate stereoselectivity. Dog liver esterases also showed stereoselectivity towards the (-)-enantiomer but dog skeletal muscle esterases did not. Studies in mongrel dogs indicated that during esmolol infusions the concentration ratio of (-)-esmolol/(+)-esmolol was approximately 0.85. After termination of the esmolol infusion the (-)/(+) concentration ratio continuously decreased until (-)-esmolol was no longer quantifiable. These results indicate that stereoselective hydrolysis of esmolol occurs in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900735

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  12 in total

1.  The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat.

Authors:  S H Haidar; J E Moreton; Z Liang; J F Hoke; K T Muir; N D Eddington
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

2.  Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.

Authors:  D B Mendel; C Y Tai; P A Escarpe; W Li; R W Sidwell; J H Huffman; C Sweet; K J Jakeman; J Merson; S A Lacy; W Lew; M A Williams; L Zhang; M S Chen; N Bischofberger; C U Kim
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.

Authors:  W Li; P A Escarpe; E J Eisenberg; K C Cundy; C Sweet; K J Jakeman; J Merson; W Lew; M Williams; L Zhang; C U Kim; N Bischofberger; M S Chen; D B Mendel
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.

Authors:  Ervin Pejo; Rile Ge; Natalie Banacos; Joseph F Cotten; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

Review 5.  Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.

Authors:  D Wiest
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

6.  Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues.

Authors:  Maria Morak; Hannes Schmidinger; Gernot Riesenhuber; Gerald N Rechberger; Manfred Kollroser; Guenter Haemmerle; Rudolf Zechner; Florian Kronenberg; Albin Hermetter
Journal:  Mol Cell Proteomics       Date:  2012-09-13       Impact factor: 5.911

7.  Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.

Authors:  S Shaukat Husain; Ervin Pejo; Rile Ge; Douglas E Raines
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

8.  Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates.

Authors:  Yuji Sakurai; Shen-Feng Ma; Hiroshi Watanabe; Noriyuki Yamaotsu; Shuichi Hirono; Yukihisa Kurono; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

9.  Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334.

Authors:  C S Cook; P J Karabatsos; G L Schoenhard; A Karim
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

10.  Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.

Authors:  Rile Ge; Ervin Pejo; Joseph F Cotten; Douglas E Raines
Journal:  Crit Care       Date:  2013-01-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.